Related Experiment Video
Updated: Feb 9, 2026

An Emerging Target Paradigm to Evoke Fast Visuomotor Responses on Human Upper Limb Muscles
Published on: August 25, 2020
Genomics-driven oncology: framework for an emerging paradigm
1Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. levi_garraway@dfci.harvard.edu
Abstract:
A majority of cancers are driven by genomic alterations that dysregulate key oncogenic pathways influencing cell growth and survival. However, the ability to harness tumor genetic information for its full clinical potential has only recently become manifest. Over the past several years, the convergence of discovery, technology, and therapeutic development has created an unparalleled opportunity to test the hypothesis that systematic knowledge of genomic information from individual tumors can improve clinical outcomes for many patients with cancer. Rigorous evaluation of this genomics-driven cancer medicine hypothesis will require many logistic innovations that are guided by overarching conceptual advances in tumor genomic profiling, data interpretation, clinical trial design, and the ethical return of genetic results to oncologists and their patients. The results of these efforts and the rigor with which they are implemented will determine whether and how comprehensive tumor genomic information may become incorporated into the routine care of patients with cancer.
Insights
Genomic alterations drive most cancers, but harnessing tumor genetic information is a new frontier. Systematic genomic profiling may improve cancer patient outcomes, pending rigorous evaluation and logistical innovations.
Area of Science:
- Oncology
- Genomics
- Translational Medicine
Background:
- Most cancers originate from genomic alterations disrupting critical oncogenic pathways.
- The clinical utility of tumor genetic information is increasingly recognized.
- Advances in discovery, technology, and therapeutics enable testing of genomics-driven cancer medicine.
Purpose of the Study:
- To evaluate the hypothesis that systematic tumor genomic profiling improves patient outcomes.
- To identify necessary innovations for implementing genomics-driven cancer medicine.
- To determine the integration of comprehensive tumor genomic information into routine cancer care.
Main Methods:
- Systematic tumor genomic profiling.
- Advanced data interpretation strategies.
- Innovative clinical trial designs.
- Ethical frameworks for returning genetic results.
Main Results:
- The convergence of discovery, technology, and therapeutics presents an opportunity to test the genomics-driven medicine hypothesis.
- Rigorous evaluation is required to validate the clinical benefits of comprehensive tumor genomic information.
- Logistical and conceptual innovations are essential for successful implementation.
Conclusions:
- The hypothesis that systematic knowledge of individual tumor genomic information can improve clinical outcomes requires rigorous validation.
- Successful integration of comprehensive tumor genomic information into routine care depends on logistical innovations and robust evaluation.
- The future of cancer care may be significantly shaped by the effective implementation of genomics-driven strategies.
Related Concept Videos
Introduction Cardiac Emergencies
Genomics
Emerging Adulthood
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Genome Size and the Evolution of New Genes
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

